Publisher
source

Dr M van der Kamp

Top university

2 years ago

Funded PhD- Overcoming ß-lactamase-mediated antibiotic resistance by combining biomolecular simulation and experiment University of Bristol in United Kingdom

Degree Level

PhD

Field of study

Pharmacology

Funding

Fully Funded

Deadline

Expired

Country flag

Country

United Kingdom

University

University of Bristol

Suggested positions

Publisher
source

University of Leicester

Country flag

United Kingdom

The University of Leicester is offering fully funded PhD projects through the BBSRC Midlands Integrative Biosciences Training Partnership (MIBTP), based in the Department of Molecular and Cell Biology and the Leicester Institute of Structural and Chemical Biology. The projects are hosted in the AKV Lab, led by Dr. Abhinav KV. Two research projects focus on structural biology, antimicrobial resistance, horizontal gene transfer and virology. Students will combine cryo-electron microscopy (cryo-EM)...

Biochemistry
Molecular Biology
Microbiology
+6 more

1 week ago

Publisher
source

Suyang Zhang

MRC Laboratory of Molecular Biology

Country flag

United Kingdom

Suyang Zhang’s team at the MRC Laboratory of Molecular Biology (MRC-LMB) is recruiting a PhD student and a postdoctoral researcher to investigate co-transcriptional splicing , also described as transcription-coupled splicing. The research examines how splicing is coordinated with transcription and gene regulation. The projects will use cryo-electron microscopy (cryo-EM) and biochemistry to study the molecular structures and mechanisms underlying co-transcriptional splicing. The positions are bas...

Biochemistry
Molecular Biology
Biology
+3 more

4 days ago

Publisher
source

Jody Mason

University of Bath

Country flag

United Kingdom

University of Bath is recruiting a Postdoctoral Research Associate in an interdisciplinary project focused on mammalian cell biology , molecular biology , chemical biology , and peptide screening . The work will develop innovative intracellular peptide screening technologies to investigate and modulate transcription factor function in living mammalian cells. The post is hosted in Professor Jody Mason's research group at the University of Bath and is funded through a new BBSRC Pioneer Award . The...

Biochemistry
Molecular Biology
Chemistry
+3 more

2 weeks ago

Publisher
source

Medical Research Council (Cambridge)

Country flag

United Kingdom

PhD opportunity in pathological protein assembly in neurodegenerative diseases at the Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom . The project is centered on the molecular pathology of neurodegeneration, with a focus on amyloid filament formation by disease-associated proteins such as TDP-43 , annexin A11 , and TAF15 . Two PhD project directions are described. One aims to reproduce pathological protein filament structures in vitro using protein biochemist...

Cell Biology
Biochemistry
Molecular Biology
+3 more

1 month ago

Publisher
source

University of Dundee

Country flag

United Kingdom

PhD opportunity at the University of Dundee in the Faculty of Life Sciences on the project EASTBIO - Uncovering the non-canonical proteolytic activity of Deubiquitinating enzymes . This discovery-driven PhD sits at the interface of biochemistry , structural biology , cell biology , biophysics , and proteomics . The project focuses on ubiquitin-deconjugating enzymes (DUBs), especially the USP family, and their newly identified non-canonical “cleave-to-modify” activity. The research aims to define...

Cell Biology
Biochemistry
Molecular Biology
+7 more

1 month ago

Keywords

Pharmacology
Biochemistry
Molecular Biology
Chemistry
Medicine
Biology
Structural Biology
Computational Chemistry
Antimicrobial Resistance
Antibiotic Resistance
X-ray Crystallography
Public Engagement
High-performance Computing (hpc)
Enzyme Kinetics
Computational Analysis
Biological Sciences
Resistance Conferring Activity
Molecular Determinants
Experiment
X-ray Facilities
Biomolecular Simulation
Antibiotic Susceptibility
Β-lactamases

More like this

About this position

Antibiotic resistance threatens human health. ß-lactamases cause resistance to ß-lactams, the most widely used antibiotics. Class C ßlactamases are not well understood, but variants are emerging that help bacteria evade even ‘last resort’ treatments. Combining computer simulation and experimental methods can explain how, guiding us to regain the upper hand in the ‘biochemical warfare’ between humans and bacteria.Rising antibiotic resistance is a major problem for human health. Resistance to ß-lactams, the single most important antibiotic class, usually arises through their breakdown by ß-lactamases (BLs). Many BL producing bacteria are multi-drug resistant and may cause untreatable infections. Worryingly, new BL variants conferring resistance are detected frequently. Several BLs that are currently widely distributed world-wide are from the BL classes A, B and D. However, class C BLs are increasingly detected and involved in causing resistance against ‘lastresort’ treatments such as the ceftazidime-avibactam (AviCaz) antibiotic-inhibitor combination therapy. We have previously shown that for BLclasses A & D, structural and kinetic data combined with multiscale simulations provides detailed insight into the molecular determinants of resistance conferring activity (e.g. ACS Catal 2020, 2022, 2024; ACS Infect Diseas 2022; JACS 2023). In part due to the relative lack of experimental data, this is a challenge for class C BLs. Therefore, this multidisciplinary project aims to combine simulation, structure determination and enzyme kinetics to understand class C BL-driven resistance against key antibiotic treatments.The proposed project will focus on two key aspects: breakdown of cephalosporin ß-lactam antibiotics (BLAs) by class C BLs and the inhibition of class C BLs by diazabicyclooctanone (DBO) and other ßlactamase inhibitors (BLIs). These two together will determine the resistance that BLs will confer against ‘last resort’ BLA/BLI combination therapies. Throughout, computational and experimental work will be closely integrated. Computational analysis of crucial interactions, catalytic mechanisms, reaction intermediates and conformational behaviour (Vander Kamp, Mulholland) will test hypotheses and help analyse enzyme kinetics (Tooke, Spencer). X-ray crystallography (Tooke, Spencer) will provide the necessary structural data to verify initial hypotheses and allow additional computational modelling. The project will focus on a set of Class C BLs from both chromosomal and plasmid origin where changes in different regions have been shown to increase resistance. Initially, outstanding questions on the detailed mechanism will be addressed. Then, multiscale computational ‘assays’ will be designed to efficiently predict activity differences (by comparison to existing and new experimental data). This is likely challenging, as exact structures of the variants of interest in complex with the BLAs and BLIs are typically not available. Alongside using recent advances in AI structure prediction (e.g. AlphaFold), structures of selected BL-BLA/BLI complexes will be determined experimentally (as these are usually not predicted with sufficient accuracy by AI-based methods). Based on the information gained, we aim to predict new putative resistance-conferring BL variants from computational screening of mutations at key positions, and validate these predictions with experimental determination of beta-lactamhydrolysis and inhibition using steady-state and stopped-flow kinetic methods, along with parallel investigation of antibiotic susceptibility in bacterial killing assays.The project will provide training in cutting-edge techniques in complementary disciplines (computational chemistry, molecular biology/biochemistry) using state-of-the-art facilities in the context of a highly collaborative AMR research environment. It will benefit from Bristol and GW4’s excellent access to high-performance computing and X-ray facilities.Mechanistic insights of Class C BL conferred antibiotic resistance can inform both the use of existing antibiotics and the possible development of new beta-lactam antibiotics to evade BL-mediated resistance. To accelerate knowledge transfer, findings will be discussed with our network of local and (inter)national collaborators and presented at conferences prior to publication. We will also exploit the broad interest in antimicrobial resistance through public engagement activities.ABOUT THE GW4 BIOMED2 DOCTORAL TRAINING PARTNERSHIP The partnership brings together the Universities of Bath, Bristol, Cardiff (lead) and Exeter to develop the next generation of biomedical researchers. Students will have access to the combined research strengths, training expertise and resources of the four research-intensive universities, with opportunities to participate in interdisciplinary and 'team science'. The DTP has already awarded over 90 studentships across 6 cohorts in its first phase, along with 58 students over 3 cohorts in its second phase.   HOW TO APPLY Please complete an application to the GW4 BioMed2 MRC DTP for an ‘offer of funding’ on GW4 BioMed MRC DTP - GW4 BioMed MRC DTP Please complete the online application form linked from the DTP’s website by 5.00pm on Monday, 4th November 2024. If you are shortlisted for interview, you will be notified from Friday, 20th December 2024. Interviews will be held virtually on 23rd and 24th January 2025. Studentships will start on 1st October 2025. If successful, you will also need to make an application for an 'offer to study' at University of Bristol. Instructions for doing this will be provided nearer the time. Application Enquiries For enquiries relating to the DTP programme or funding, please contact [email protected] Please contact the project supervisor for project-related queries. 

Funding details

Fully Funded

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts and confirm requirements with the university.

Professors

School of Biochemistry

University Name
Country flag

United Kingdom

Research Interests

Pharmacology

Biochemistry

Chemistry

Biology

Biomolecular Simulation